Stockreport

Perspective Therapeutics Provides Business Updates and Strategic Priorities Ahead of Presentation at 44th Annual J.P. Morgan Healthcare Conference

Perspective Therapeutics, Inc.  (CATX) 
PDF Continued strong patient recruitment in neuroendocrine tumors for lead program VMT-a-NET sets the stage for submissions of robust clinical data package for presentat [Read more]